On June 23, 2022 Pfizer Inc. (NYSE: PFE) reported that its board of directors declared a $0.40 third-quarter 2022 dividend on the company’s common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29, 2022 (Press release, Pfizer, JUN 23, 2022, View Source [SID1234616212]). The third-quarter 2022 cash dividend will be the 335th consecutive quarterly dividend paid by Pfizer.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!